chr1-244835747-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_198076.6(COX20):c.33G>T(p.Glu11Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E11K) has been classified as Uncertain significance.
Frequency
Consequence
NM_198076.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX20 | ENST00000411948.7 | c.33G>T | p.Glu11Asp | missense_variant | 1/4 | 1 | NM_198076.6 | ENSP00000406327.2 | ||
COX20 | ENST00000391839.6 | n.92G>T | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
COX20 | ENST00000366528.3 | c.33G>T | p.Glu11Asp | missense_variant | 1/5 | 2 | ENSP00000355486.3 | |||
COX20 | ENST00000498262.1 | n.89G>T | non_coding_transcript_exon_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1120230Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 536364
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial complex 4 deficiency, nuclear type 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 07, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.